BAJAJFINSV vs SUNPHARMA: Stock Comparison
Sun Pharmaceutical Industries Ltd is the larger company by market capitalisation. Bajaj Finserv Ltd shows a lower P/E, while Sun Pharmaceutical Industries Ltd shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BAJAJFINSV leads 4; SUNPHARMA leads 8 of 12
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BAJAJFINSV | SUNPHARMA |
|---|---|---|
| Sector | Financial Services | Healthcare |
| Industry | Holding Company | Pharmaceuticals |
Price
| Metric | BAJAJFINSV | SUNPHARMA |
|---|---|---|
| Live Price | ₹2,025 | ₹1,932 |
| Day Change | 0.22% | -0.62% |
| Volume | 8.89 L | 12.16 L |
| 52-Week High | ₹2,195 | ₹2,046.9 |
| 52-Week Low | ₹1,597 | ₹1,548 |
| Distance from 52W High | -7.74% | -5.61% |
Valuation
| Metric | BAJAJFINSV | SUNPHARMA |
|---|---|---|
| Market Cap | ₹3.23 L Cr | ₹4.66 L Cr |
| P/E Ratio | 31.67x | 38.39x |
| P/B Ratio | 4.13x | 5.56x |
| EPS | ₹63.2 | ₹50.49 |
| Book Value | ₹487.35 | ₹348.31 |
| Dividend Yield | 0.06% | 0.82% |
Growth
| Metric | BAJAJFINSV | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 5.3% | 12.8% |
| EPS Growth (TTM YoY) | 5.7% | 25.6% |
| Qtr Sales Growth | 5.19% | 10.5% |
| Qtr Profit Growth | 5.05% | 5.95% |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | BAJAJFINSV | SUNPHARMA |
|---|---|---|
| ROE | 13.2% | 16% |
| ROCE | 10.6% | 20.5% |
| Net Margin | 7.66% | 18.56% |
| Operating Margin | 37.9% | 29.8% |
| Debt to Equity | 5.52x | 0.06x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | BAJAJFINSV | SUNPHARMA |
|---|---|---|
| Promoter Holding | 58.7% | 54.48% |
| FII Holding | 6.91%▼ 0.33 pp | 14.53%▼ 1.4 pp |
| DII Holding | 12.1%▲ 0.34 pp | 22.18%▲ 1.07 pp |
| Public Holding | 22.23%▲ 0.07 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bajaj Finserv Ltd and Sun Pharmaceutical Industries Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.